Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-29

Clinical Trial Update: A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular Prurigo [Phase 3]

View source ↗

Summary

This is a Phase 3 randomized, double-blinded, self-controlled clinical trial evaluating intralesional injections of 5-fluorouracil plus triamcinolone for refrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Triamcinolone (triamcinolone)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Nodular Prurigo | Phase 3 | Status: NOT_YET_RECRUITING